共 50 条
- [31] The Profiling of Circulating Tumor DNA in Pediatric Mature B-Cell Non-Hodgkin Lymphoma(B-NHL): A Multicenter, Prospective Clinical StudyPEDIATRIC BLOOD & CANCER, 2021, 68 : S79 - S79Wang, J.Yun, C.Huiqin, C.Liangchun, Y.Guo, H.Huihong, D.Xin, T.Xiaoyu, H.Chuqiao, L.Zhen, Z.Zhu, S.Lu, S.Sun, F.Huang, J.Zhang, Y.
- [32] ADVANCED BURKITT-TYPE NON-HODGKIN LYMPHOMA (B-NHL) IN CHILDHOOD - RESULTS OF AN INTENSIVE SHORT-TERM CHEMOTHERAPY REGIMENMEDICAL AND PEDIATRIC ONCOLOGY, 1987, 15 (06): : 336 - 336FOSSATIBELLANI, FLOMBARDI, FGIANNI, CGASPARINI, MROTTOLI, LBALLERINI, EMORANDI, F
- [33] Chromosomal Alterations in Gene Expression-Defined Pediatric Aggressive B-Cell Non-Hodgkin Lymphoma (B-NHL)BLOOD, 2009, 114 (22) : 1142 - 1142Deffenbacher, Karen E.Iqbal, JaveedLiu, ZhongfengPerkins, Sherrie L.Lim, Megan S.Fu, KaiShen, YuleiStaudt, Louis M.Rimsza, Lisa M.Jaffe, Elaine S.Rosenwald, AndreasOtt, GermanDelabie, JanCampo, EliasGascoyne, Randy D.Weisenburger, Dennis D.Greiner, Timothy C.Gross, ThomasChan, Wing C.
- [34] Relationship between exposure and safety/efficacy of loncastuximab tesirine (Lonca) in B-cell non-Hodgkin lymphoma (B-NHL).CANCER RESEARCH, 2021, 81 (13)Hess, BrianAi, WeiyunTownsend, WilliamUngar, DavidLiao, SamLiao, LoriZhang, XiaoyanBoni, Joseph
- [35] Phase I study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin's lymphoma (NHL).BLOOD, 2000, 96 (11) : 577A - +Ansell, SMWitzig, TEKurtin, PJJelinek, DFHowell, KGMarkovic, SNHabermann, TMKlee, GGSloan, JAErlichmann, C
- [36] HEPATIC TOXICITY IN PATIENTS WITH NON HODGKIN'S LYMPHOMA (NHL) INFECTED WITH HEPATITIS C UNDERGOING CHEMOTHERAPY WITH RITUXIMABANNALS OF ONCOLOGY, 2011, 22 : 226 - 226Lepkov, S.Storogakov, G.Kovrigina, A.Tumyn, G.Kosura, S.Kolomeytsev, O.Zeynalova, P.Kondratieva, T.Melkova, K.Ettinger, O.Subortseva, I.Timofeeva, O.
- [37] Analysis of prognostic factors and pharmacodynamic parameters in relapsed indolent B-NHL and mantle cell lymphoma (MCL) treated with rituximab.BLOOD, 2000, 96 (11) : 249B - 249BTobinai, KIgarashi, TOgura, MKinoshita, TKobayashi, YSasaki, YMorishima, YUike, NTaniwaki, MKano, YKasai, MOhnishi, K
- [38] Randomized phase II study of concurrent and sequential combinations of rituximab (R) plus CHOP (R-CHOP) in untreated indolent B-cell non-Hodgkin's lymphoma (B-NHL).JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 576S - 576STobinai, KWatanabe, TOgura, MMorishima, YItoh, KIgarashi, THotta, TKinoshita, TMori, SOhashi, Y
- [39] Hepatitis B virus reactivation in a case of Non-Hodgkin's lymphoma treated with chemotherapy and rituximab: Necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapyLEUKEMIA & LYMPHOMA, 2004, 45 (03) : 627 - 629Tsutsumi, YKawamura, TSaitoh, SYamada, MObara, SMiura, TKanamori, HTanaka, JAsaka, MImamura, MMasauzi, N
- [40] Low level of cerebrospinal fluid (CSF) rituximab (RTX) following intravenous rituximab in children, adolescents and young adults (CAYA) with de novo mature B-cell Non-Hodgkin lymphoma (B-NHL)BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 47 - 47Barth, Matthew J.Chu, YayaGoldman, Stanton C.Hochberg, JessicaOesterheld, JavierHeym, KennethHarrison, LaurenMahanti, HarshiniFlowers, AllysonBasso, JackieCairo, Mitchell S.